FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at preventing development of corneal opacity in case of mechanical injuries. To prevent development of corneal opacity after its mechanical injuries subconjunctival injections and external applications in the form of drops on the corneal wound of the solution are carried out. Above solution is prepared using oxyethyl ammonium methylphenoxy acetate powder and 0.9 % sodium chloride solution. Components are used in claimed amounts. Said components are mixed ex tempore until complete dissolution of oxyethyl ammonium methylphenoxy acetate powder. Subconjunctival injections are 0.5 ml once a day daily, applications – 2 drops 2 times a day, 1 time in morning and 1 time in the evening, course of 7 days.
EFFECT: use of the invention provides prevention of corneal opacity in case of mechanical injuries in all cases of its use.
1 cl, 6 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ACCELERATING CORNEAL HEALING ACCOMPANYING MECHANICAL INJURIES | 2019 |
|
RU2701178C1 |
| USE OF METHYLPHENOXYACETATE OXYETHYLAMMONIUM SOLUTION | 2019 |
|
RU2706715C1 |
| METHOD FOR PREVENTING DEVELOPMENT OF CORNEAL OPACITY IN CASE OF MECHANICAL INJURIES | 2019 |
|
RU2704354C1 |
| METHOD OF ACCELERATING CORNEAL HEALING ACCOMPANYING MECHANICAL INJURIES | 2019 |
|
RU2700589C1 |
| USE OF OXYETHYLAMMONIUM SOLUTION OF METHYLPHENOXYACETATE | 2019 |
|
RU2703302C1 |
| METHOD OF TREATING CORNEAL BURNS | 2021 |
|
RU2766298C2 |
| LIQUID PHARMACEUTICAL COMPOSITION OXYETHYLAMMONIUM METHYLPHENOXYACETATE | 2021 |
|
RU2783660C2 |
| METHOD FOR TREATING CORNEA DEFECT CASES | 2004 |
|
RU2279887C2 |
| USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND ZINC BIS-(2-METHYLPHENOXY-ACETATE) (ZINCATRAN) AS HYPOLIPIDEMIC (ANTIATHEROSCLEROTIC) AGENT | 2014 |
|
RU2575788C1 |
| DRUG INCREASING INTENSITY OF PRENATAL IMMUNOGENESIS IN EXPERIMENTAL ANIMALS | 2023 |
|
RU2813129C1 |
